The incidence of recurrent GBM is increasing globally due to several factors such as aging population, exposure to environmental carcinogens, and genetic predisposition. According to the American Brain Tumor Association, GBM accounts for about 15% of all primary brain tumors and occurs in approximately 3 out of every 100,000 people in the United States. Moreover, the recurrence rate of GBM is very high, with up to 90% of patients experiencing a relapse within two years of initial diagnosis.
The increasing prevalence of recurrent GBM is driving the demand for effective treatment options, which is fueling the growth of the Recurrent Glioblastoma Multiforme Treatment Market. The recurrent GBM treatment market is also benefiting from increasing awareness and patient education. Several patient advocacy groups and non-profit organizations are working to raise awareness about GBM and provide support to patients and their families. Moreover, the availability of online resources and support groups is making it easier for patients to access information about their condition and treatment options. The increasing awareness and patient education are expected to drive the demand for effective treatment options.
Read more @ https://creativeedge16.blogspot.com/2023/03/recurrent-glioblastoma-multiforme.html
